Delling D, Schulz A, Ziegler R
Acta Med Austriaca. 1977;4(4-9):172-9.
Bone alterations in Paget's disease, have been studied by histomorphometrical evaluation iliac creat bone biopsies before and after long-term treatment with human ans salmon calcitonin. Therapeutic effect was controlled from 12, up to 48 months. All-together 28 bone biopsies were taken from 9 patients (aged 46 to 71 years) with Paget's disease of their os ileum. The biopsies were prepared for histological examination without previous decalcification, cut, stained and quantitatively analysed at the light microscopic level. By means of a point counting method we determined the parameters of bone structure, bone formation and bone resorption. Before therapy was started, trabecular bone alterations could be observed which were typical for Paget's disease of bone as there were bulky trabeculare, increased remodelling surfaces and giant osteoclasts. Following treatment with calcitonin a dramatic reduction of bone remodelling surfaces and a normalization of bone structure occurs. Considering our previous electon microscopy findings, a reduction of the number of osteoclasts as well as their nuclear content, might be explained by an inhibitory effect of calcitonin on cell fusion of osteoclastic precursor cells. In 2 cases, an interruption or hormonal treatment of 5 to 12 months, presented no risk of losing the therapeutic effect.
通过对9例(年龄46至71岁)患有髂骨佩吉特病患者的髂嵴骨活检进行组织形态计量学评估,研究了佩吉特病的骨改变情况。在接受人降钙素和鲑鱼降钙素长期治疗前后均进行了评估。治疗效果在12至48个月内得到监测。总共从9例患者的髂骨获取了28份骨活检样本。活检样本未预先脱钙,直接进行组织学检查,切片、染色后在光学显微镜下进行定量分析。通过点计数法,我们确定了骨结构、骨形成和骨吸收的参数。在开始治疗前,可以观察到典型的佩吉特病骨小梁改变,如粗大的骨小梁、增加的重塑表面和巨大的破骨细胞。降钙素治疗后,骨重塑表面显著减少,骨结构恢复正常。结合我们之前的电子显微镜观察结果,降钙素对破骨细胞前体细胞的细胞融合具有抑制作用,这可能解释了破骨细胞数量及其核含量的减少。在2例患者中,中断5至12个月的激素治疗,并未出现失去治疗效果的风险。